Status:
UNKNOWN
Appendectomy and Colorectal Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Colorectal Cancer
Appendicitis
Eligibility:
All Genders
Brief Summary
Colorectal cancer (CRC) is one of the most common cancer worldwide. Initiation and progression of CRC involve complex interactions among genetic, epigenetic and environmental factors. Given that hered...
Eligibility Criteria
Inclusion
- Individuals underwent appendectomy from January 2000 to December 2020
Exclusion
- patients with the age ≤18 years at enrollment;
- Patients with any malignant diseases or inflammatory bowel disease history before enrollment;
- Patients with hereditary syndromes of colorectal adenomas or polyps (familial adenomatous polyposis, Lynch syndrome, etc.);
- Patients that underwent appendectomy for appendiceal neoplasms.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
180000 Patients enrolled
Trial Details
Trial ID
NCT06091137
Start Date
June 1 2022
End Date
May 31 2025
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Digestive Disease, The Chinese University of Hong Kong
Shatin, Hong Kong, 00000